Previous 10 | Next 10 |
IVERIC bio, Inc. (Nasdaq: ISEE) (the “Company”), today announced the pricing of an underwritten public offering of 11,650,000 shares of its common stock at a price to the public of $8.60 per share, less underwriting discounts and commissions. In addition, in connection wit...
DNY59/E+ via Getty Images IVERIC bio ("ISEE") shares are down 4.9% to $8.57 in after-hours trading after the company announced it was commencing a public offering of $100M of common stock. The shelf registration was declared effective on April 9. Cowen, Credit Suisse, and Stifel are...
4 Top Health Care Stocks To Watch In The Stock Market Today Whether we acknowledge it or not, health care stocks are part of one of the most significant sectors in the stock market today . The companies in the industry range from those that sell medical supplies, offer medical s...
Newegg Commerce NEGG +148%.Mannatech (MTEX) +50%.Data Storage (DTST) +33%.iPower (IPW) +32%.Peabody Energy BTU +25%.Dare Bioscience (DARE) +24%.Vivos Therapeutics (VVOS) +24%.Exela Technologies (XELA) +23%.OncoSec Medical (ONCS) +22%.Opiant Pharmaceuticals (OPNT) +21%.SM...
IVERIC bio Inc. (NASDAQ:ISEE) traded today at a new 52-week high of $9.37. This new high was reached on approximately average trading volume as 1.4 million shares traded hands, while the average 30-day volume is approximately 1.1 million shares. IVERIC bio Inc is a biopharmaceutical comp...
Zarina Lukash/iStock via Getty Images Before the market opened today, IVERIC bio ([[ISEE]] +11.1%) announced that the FDA agreed to a Special Protocol Assessment ((SPA)) for its late-stage trial GATHER2 for Zimura (avacincaptad pegol) in geographic atrophy secondary to age-related macular deg...
Tonpor Kasa/iStock via Getty Images IVERIC bio (ISEE) shares are up 5% in premarket trading after the FDA agreed to a Special Protocol Assessment for a phase 3 clinical trial of Zimura (avacincaptad pegol) for geographic atrophy secondary to age-related macular degeneration. In addi...
Weibo WB +43% on report that Chairman Chao, investor in talks for at least $20B buyout.Bridgeline Digital (BLIN) +35%.BSQUARE (BSQR) +32%.Marin Software (MRIN) +26%.Axcella Health (AXLA) +23%.Odonate Therapeutics (ODT) +21%.Ocugen OCGN +19% Shares extended gains after part...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, investors, and I hope you all enjoyed the July 4th weekend! We’re getting right back into the swing of things today with a look at the biggest pre-market stock movers for Tuesday! Source: f11photo/S...
- GATHER2 Enrollment and Retention Continue to Exceed Expectations; Completion of Enrollment Expected Late July of this Year and Topline Data Expected Second Half of 2022 - - Conference Call and Webcast Today, July 6, 2021, at 8:00 a.m. ET - IVERIC bio, Inc. (Nas...
News, Short Squeeze, Breakout and More Instantly...
Astellas Completes Acquisition of Iveric Bio PR Newswire TOKYO and PARSIPPANY, N.J. , July 11, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura , "Astellas") today announced that it has successfully completed the acquisit...
Shares of IVERIC bio, Inc. (NASDAQ: ISEE) traded at a new 52-week high today and are currently trading at $39.73. So far today, approximately 1.78M shares have been exchanged, as compared to an average 30-day volume of 5.04M shares. IVERIC bio, Inc., a biopharmaceutical company, discovers and...
IVERIC bio, Inc. (NASDAQ: ISEE) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 1.93% on the day to $38.77. IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal disease...